Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat

Circulation Journal

Volumn 67, Issue 8, 2003, Pages 705-711

  Satoh, Shinji ^a   Ueda, Yasuko ^a   Suematsu, Nobuhiro ^a   Oyama, Jun Ichi ^a   Kadokami, Toshiaki ^a   Sugano, Masahiro ^a   Yoshikawa, Yasuji ^a   Makino, Naoki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor (ACEI); Calcium; Heart failure; Hypertrophy; Sarcoplasmic reticulum

Indexed keywords

8 BROMO CYCLIC AMP; CAFFEINE; CALCIUM ION; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHOLAMBAN; SERINE; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL SIZE; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART PAPILLARY MUSCLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HIGH SODIUM INTAKE; HYPERTENSION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; SARCOPLASMIC RETICULUM; WESTERN BLOTTING;

EID: 0042594378     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.705     Document Type: Article

References (39)

1. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69: 475-482.
2. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-1865.
3. Backer KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992; 54: 227-241.
4. Dorn GW II, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 1999; 9: 26-34.
5. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, et al. Molecular mechanisms of angiotensin II in modulating cardiac function: Intracellular effects and signal transduction pathways. J Mol Cell Cardiol 1997; 29: 2893-2902.
6. Nagata K, Somura F, Obata K, Odashima M, Izawa H, Ichihara S, et al. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension 2002; 40: 168-174.
7. Katz AM. Proliferative signaling and disease progression in heart failure. Circ J 2002; 66: 225-231.
8. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe heart failure. N Engl J Med 1987; 316: 1429-1435.
9. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 352: 293-302.
10. Linz W, Schoelkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989; 11: 1325-1350.
11. Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 1992; 86: 1566-1574.
12. Kobayashi N, Hara K, Higashi T, Matsuoka H. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats. Am J Hypertens 2000; 13: 1088-1096.
13. Inoko M, Fujita M, Nakae I, Tamaki S, Watanuki M, Hashimoto T, et al. Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure. Jpn Circ J 2001; 65: 395-398.
14. Yamaguchi F, Sanbe A, Takeo S. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction. Br J Pharmacol 1998; 123: 326-334.
15. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S, Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 1994; 267: H2471-H2482.
16. Satoh S, Ueda Y, Koyanagi M, Kadokami T, Sugano M, Makino N. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. J Mol Cell Cardiol 2003; 35: 59-70.
17. Satoh S, Makino N. Intracellular mechanisms of cGMP-mediated regulation of myocardial contraction. Basic Res Cardiol 2001; 96: 652-658.
18. De Tombe PP, Wannenburg T, Fan D, Little WC. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am J Physiol 1996; 271: H73-H79.
19. Perreault CL, Shannon RP, Komamura K, Vatner SF, Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest 1992; 89: 932-938.
20. Pérez NG, Hashimoto K, McCune S, Altschuld RA, Marbán E. Origin of contractile dysfunction in heart failure: Calcium cycling versus myofilaments. Circulation 1999; 99: 1077-1083.
21. 2+ accumulation in skinned fibers of hypertrophied rat heart. Am J Physiol 1994; 266: H749-H756.
22. Makino N, Sugano M, Otsuka S, Hata T. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 1997; 30: 796-802.
23. Hayakari M, Kondoh Y, Ihumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem 1978; 84: 361-369.
24. Masutomo K, Makino N, Sugano M, Miyamoto S, Hata T, Yanaga T. Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio 14.6 and Bio 53.58 hamsters. J Mol Cell Cardiol 1999; 31: 1607-1615.
25. 2+-sensitivity of SERCA 2a in failing human myocardium due to reduced Serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 1999; 31: 479-491.
26. Hayashida W, Kihara Y, Yasaka A, Sasayama S. Cardiac calcineurin during transition from hypertrophy to heart failure in rats. Biochem Biophys Res Commun 2000; 273: 347-351.
27. Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001; 103: 148-154.
28. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995: 47: 25-29.
29. Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, et al. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988; 22: 686-695.
30. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol 1997; 92(Suppl 1): 87-93.
31. Katz AM. Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate on the myocardial cell. Circulation 1990; 82(Suppl I): I-7-I-11.
32. Huang B, Wang S, Qin D, Boutjdir M, El-Sherif N. Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: Role of β-adrenergic pathway, Gi protein, phosphodiesterase, and phosphatases. Circ Res 1999; 85: 848-855.
33. Sande JB, Sjaastad I, Hoen IB, Bøkenes J, Tønnessen T, Holt E, et al. Reduced level of Ser16 phosphorylated phospholamban in the failing rat myocardium: A major contributor to reduced SERCA2 activity. Cardiovasc Res 2002; 53: 382-391.
34. Yoneda T, Kihara Y, Ohkusa T, Iwanaga Y, Inagaki K, Takeuchi Y, et al. Calcium handling and sarcoplasmic-reticular protein functions during heart-failure transition in ventricular myocardium from rats with hypertension. Life Sci 2001; 70: 143-157.
35. Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA. Mechanisms of β adrenoceptor desensitization in the failing human heart. Cardiovasc Res 1994; 28: 1451-1460.
36. Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz H, et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997; 29: 265-272.
37. Zakhary DR, Moravec CS, Stewart RW, Bond M. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 1999; 99: 505-510.
38. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts: Role of phosphatases and response to isoproterenol. J Biol Chem 2003; 278: 444-453.
39. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000; 101: 365-376.